These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38604949)

  • 1. A statistical investigation of parameters associated with low cell-free fetal DNA fraction in maternal plasma for noninvasive prenatal testing.
    Pan Y; Pan X; Zhuang D; Zhou Y; Xue J; Wu S; Chen C; Li H
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2338440. PubMed ID: 38604949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between fetal fraction of cell-free DNA and adverse pregnancy outcomes.
    Golbasi H; Bayraktar B; Golbasi C; Omeroglu I; Adiyaman D; Alkan KO; Ozdemir TR; Ozer OK; Ozyilmaz B; Ekin A
    Arch Gynecol Obstet; 2024 Aug; 310(2):1037-1048. PubMed ID: 38441603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell free DNA screening for fetal aneuploidy in Ireland: An observational study of outcomes following insufficient fetal fraction.
    Creswell L; Doddy F; Manning C; Nazir SF; Lindow SW; Lynch C; O'Gorman N
    Eur J Obstet Gynecol Reprod Biol; 2023 Nov; 290():143-149. PubMed ID: 37797414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester screening for trisomies in pregnancies with vanishing twin.
    Chaveeva P; Wright A; Syngelaki A; Konstantinidou L; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):326-331. PubMed ID: 31710734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of maternal blood pregnancy-associated plasma protein A (PAPP-A) and free beta-subunit of human chorionic gonadotropin (β-hCG) levels for the risk assessment of fetal trisomy 18 during the first prenatal testing between 11 and 13+6 weeks of pregnancy.
    Ziolkowska K; Tobola-Wrobel K; Dydowicz P; Zurawski S; Pietryga M; Wysocka E
    Ginekol Pol; 2020; 91(12):748-754. PubMed ID: 33447994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal fraction of cell-free DNA in pregnancies after fresh or frozen embryo transfer following assisted reproductive technologies.
    Talbot AL; Ambye L; Hartwig TS; Werge L; Sørensen S; Stormlund S; Prætorius L; Jørgensen HL; Pinborg A; Jørgensen FS
    Hum Reprod; 2020 Jun; 35(6):1267-1275. PubMed ID: 32539141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of low fetal fraction of cell-free DNA at the early second-trimester and pregnancy complications related to placental dysfunction in twin pregnancy.
    Li J; Gu X; Wei Y; Tao Y; Zhai B; Peng C; Huang Q; Deng T; Yuan P
    Front Med (Lausanne); 2022; 9():1011366. PubMed ID: 36590958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate analysis identifies the estradiol level at ovulation triggering as an independent predictor of the first trimester pregnancy-associated plasma protein-A level in IVF/ICSI pregnancies.
    Giorgetti C; Vanden Meerschaut F; De Roo C; Saunier O; Quarello E; Hairion D; Penaranda G; Chabert-Orsini V; De Sutter P
    Hum Reprod; 2013 Oct; 28(10):2636-42. PubMed ID: 23887070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure.
    Galeva S; Gil MM; Konstantinidou L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):804-809. PubMed ID: 30977206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive prenatal testing for fetal aneuploidies in the first trimester of pregnancy.
    Song Y; Huang S; Zhou X; Jiang Y; Qi Q; Bian X; Zhang J; Yan Y; Cram DS; Liu J
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):55-60. PubMed ID: 25044397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for trisomy at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Bardani E; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):408-415. PubMed ID: 32621353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21.
    Sahota DS; Leung TY; Fung TY; Chan LW; Law LW; Lau TK
    Ultrasound Obstet Gynecol; 2009 Apr; 33(4):387-93. PubMed ID: 19306471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse perinatal outcomes are more frequent in pregnancies with a low fetal fraction result on noninvasive prenatal testing.
    Krishna I; Badell M; Loucks TL; Lindsay M; Samuel A
    Prenat Diagn; 2016 Mar; 36(3):210-5. PubMed ID: 26783737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of failure to achieve a result from prenatal maternal serum cell-free DNA testing: a historical cohort study.
    Chan N; Smet ME; Sandow R; da Silva Costa F; McLennan A
    BJOG; 2018 Jun; 125(7):848-855. PubMed ID: 29090507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting cell-free DNA fetal fraction and the consequences for test accuracy.
    Scott FP; Menezes M; Palma-Dias R; Nisbet D; Schluter P; da Silva Costa F; McLennan AC
    J Matern Fetal Neonatal Med; 2018 Jul; 31(14):1865-1872. PubMed ID: 28514925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Down syndrome in dichorionic twin pregnancies conceived by in vitro fertilization (IVF): a clinical pilot study to confirm the laboratory methods.
    Francois L; Kugler L; Santolaya JL; Faro R; Di Stefano V; Merjanian L; Santolaya-Forgas J
    J Assist Reprod Genet; 2014 Jan; 31(1):125-8. PubMed ID: 24193697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.